🔎 Trials Near Me

Home › Crohn's Disease › Indiana › Indianapolis

Crohn's Disease clinical trials in Indianapolis, IN

10 studies for Crohn's Disease are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RecruitingPhase 3
  • Indiana University Health University Hospital ( Site 5022), Indianapolis
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RecruitingPhase 2
  • Indiana University Health University Hospital /ID# 278129, Indianapolis
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2/3
  • IU Health University Hospital, Indianapolis
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07196722

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RecruitingPhase 3
  • Riley Hospital for Children, Indianapolis
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RecruitingPhase 3
  • Indiana University Health University Hospital, Indianapolis
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
Ages 2 to 17 · All sexes · Updated Sep 23, 2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RecruitingPhase 3
  • Riley Childrens Hospital, Indianapolis
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis
Ages 2 to 17 · All sexes · Updated Jun 24, 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RecruitingPhase 4
  • Riley Hospital for Children at Indiana University Health, Indianapolis
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

RecruitingPhase 2/3
  • Riley Hospital for Children, Indianapolis
Ages 6 to 22 · All sexes · Updated May 5, 2026 · NCT05660746

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.